what to expect from semaglutide for weight loss Before and After: Real Results 🌿 The Truth About Semaglutide

Premium packaging

Leading Players in the GLP-1 Market Novo Nordisk 38.72% Ozempic Wegovy Rybelsus Eli Lilly 28.41% Mounjaro Zepbound Sanofi 8.76% 4 AstraZeneca 6.62% 5 GSK 4.95% 6 Regeneron 3.27% 7 Pfizer 2.61% 8 Amgen 1.98% 9 Sun Pharma 1.52% Boehringer Ingelheim 1.24% Together, Novo Nordisk and Eli Lilly account for more than 67% of the market, highlighting the intense competition between the two companies that currently lead the obesity and diabetes treatment revolution

A growing share of employers are rethinking coverage of the weight-loss drugs as costs rise and early expectations of lower obesity rates and surgical needs have yet to surface in claims data.

No Cold Chain: Because they are chemically stable, they dont require the expensive refrigerated shipping and storage that injectables do

Up to 40% of weight lost on GLP-1 alone is lean mass